Glassman Wealth Services’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-146
| Closed | -$27.9K | – | 274 |
|
|
2023
Q4 | $27.9K | Buy |
146
+10
| +7% | +$1.91K | ﹤0.01% | 609 |
|
|
2023
Q3 | $24.1K | Sell |
136
-5
| -4% | -$886 | ﹤0.01% | 612 |
|
|
2023
Q2 | $26.8K | Buy |
141
+7
| +5% | +$1.33K | ﹤0.01% | 554 |
|
|
2023
Q1 | $26.8K | Sell |
134
-4
| -3% | -$801 | ﹤0.01% | 562 |
|
|
2022
Q4 | $32.8K | Buy |
138
+4
| +3% | +$951 | 0.01% | 529 |
|
|
2022
Q3 | $27K | Buy |
134
+2
| +2% | +$403 | 0.01% | 532 |
|
|
2022
Q2 | $19K | Sell |
132
-45
| -25% | -$6.48K | ﹤0.01% | 630 |
|
|
2022
Q1 | $29K | Buy |
177
+27
| +18% | +$4.42K | 0.01% | 533 |
|
|
2021
Q4 | $25K | Buy |
150
+13
| +9% | +$2.17K | ﹤0.01% | 545 |
|
|
2021
Q3 | $26K | Buy |
137
+2
| +1% | +$380 | 0.01% | 509 |
|
|
2021
Q2 | $23K | Buy |
135
+2
| +2% | +$341 | ﹤0.01% | 532 |
|
|
2021
Q1 | $19K | Sell |
133
-2
| -1% | -$286 | ﹤0.01% | 537 |
|
|
2020
Q4 | $18K | Buy |
135
+69
| +105% | +$9.2K | ﹤0.01% | 553 |
|
|
2020
Q3 | $10K | Buy |
66
+13
| +25% | +$1.97K | ﹤0.01% | 599 |
|
|
2020
Q2 | $8K | Buy |
53
+28
| +112% | +$4.23K | ﹤0.01% | 527 |
|
|
2020
Q1 | $3K | Buy |
25
+3
| +14% | +$360 | ﹤0.01% | 587 |
|
|
2019
Q4 | $3K | Hold |
22
| – | – | ﹤0.01% | 651 |
|
|
2019
Q3 | $2K | Buy |
22
+18
| +450% | +$1.64K | ﹤0.01% | 665 |
|
|
2019
Q2 | $0 | Sell |
4
-9
| -69% | – | ﹤0.01% | 1049 |
|
|
2019
Q1 | $1K | Buy |
+13
| New | +$1K | ﹤0.01% | 753 |
|
|
2018
Q2 | – | Sell |
-3
| Closed | – | – | 788 |
|
|
2018
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 725 |
|
|
2017
Q4 | $0 | Buy |
+3
| New | – | ﹤0.01% | 658 |
|